DE69636714D1 - G-CSF TPO Fusionsproteine - Google Patents

G-CSF TPO Fusionsproteine

Info

Publication number
DE69636714D1
DE69636714D1 DE69636714T DE69636714T DE69636714D1 DE 69636714 D1 DE69636714 D1 DE 69636714D1 DE 69636714 T DE69636714 T DE 69636714T DE 69636714 T DE69636714 T DE 69636714T DE 69636714 D1 DE69636714 D1 DE 69636714D1
Authority
DE
Germany
Prior art keywords
polypeptide
activity
csf
fusion polypeptide
fusion proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69636714T
Other languages
English (en)
Other versions
DE69636714T2 (de
Inventor
Haruhiko Yokoi
Yukimasa Shiotsu
Noboru Konishi
Hideharu Anazawa
Tatsuya Tamaoki
Motoo Yamasaki
Yoko Terasaki
Kazuhisa Uchida
Kinya Yamashita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of DE69636714D1 publication Critical patent/DE69636714D1/de
Application granted granted Critical
Publication of DE69636714T2 publication Critical patent/DE69636714T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/524—Thrombopoietin, i.e. C-MPL ligand
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69636714T 1995-04-26 1996-04-26 G-CSF TPO Fusionsproteine Expired - Fee Related DE69636714T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10262595 1995-04-26
JP10262595 1995-04-26
PCT/JP1996/001157 WO1996034016A1 (fr) 1995-04-26 1996-04-26 Nouveaux polypeptides

Publications (2)

Publication Number Publication Date
DE69636714D1 true DE69636714D1 (de) 2007-01-04
DE69636714T2 DE69636714T2 (de) 2007-10-18

Family

ID=14332430

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69636714T Expired - Fee Related DE69636714T2 (de) 1995-04-26 1996-04-26 G-CSF TPO Fusionsproteine

Country Status (8)

Country Link
EP (1) EP0783003B1 (de)
JP (1) JP3763846B2 (de)
AT (1) ATE346096T1 (de)
AU (1) AU705064B2 (de)
CA (1) CA2194070A1 (de)
DE (1) DE69636714T2 (de)
ES (1) ES2276401T3 (de)
WO (1) WO1996034016A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251864B1 (en) 1995-06-07 2001-06-26 Glaxo Group Limited Peptides and compounds that bind to a receptor
US5869451A (en) * 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
US6066318A (en) * 1995-10-05 2000-05-23 G.D. Searle & Co. Multi-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factors
US7091311B2 (en) 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
WO2002036626A1 (en) * 2000-11-02 2002-05-10 Maxygen Aps Single-chain multimeric polypeptides
ES2462916T3 (es) 2002-09-18 2014-05-26 Janssen Pharmaceuticals, Inc. Métodos para aumentar la producción de células madre hematopoyéticas y plaquetas
US20050079155A1 (en) * 2003-03-20 2005-04-14 Xencor, Inc. Generating protein pro-drugs using reversible PPG linkages
SI1675606T1 (sl) 2003-08-28 2017-07-31 Janssen Pharmaceuticals, Inc. Peptidi in spojine, ki se vežejo na trombopoietinske receptorje
US7723295B2 (en) 2003-08-28 2010-05-25 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to a receptor
WO2006041088A1 (ja) * 2004-10-12 2006-04-20 Tissue Targeting Japan Inc. 脳移行性骨髄前駆細胞

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0796558B2 (ja) * 1988-03-31 1995-10-18 協和醗酵工業株式会社 修飾ポリペプチド
AU5355790A (en) * 1989-04-19 1990-11-16 Cetus Corporation Multifunctional m-csf proteins and genes encoding therefor
JPH04103599A (ja) * 1990-08-22 1992-04-06 Toray Ind Inc 融合ポリペプチド
AU651152B2 (en) * 1990-08-29 1994-07-14 Genetics Institute, Llc Multidomain hematopoiesis stimulators
WO1992006116A1 (en) * 1990-09-28 1992-04-16 Ortho Pharmaceutical Corporation Hybrid growth factors

Also Published As

Publication number Publication date
AU705064B2 (en) 1999-05-13
CA2194070A1 (en) 1996-10-31
ES2276401T3 (es) 2007-06-16
EP0783003A1 (de) 1997-07-09
WO1996034016A1 (fr) 1996-10-31
AU5514796A (en) 1996-11-18
EP0783003A4 (de) 1998-01-07
ATE346096T1 (de) 2006-12-15
DE69636714T2 (de) 2007-10-18
EP0783003B1 (de) 2006-11-22
JP3763846B2 (ja) 2006-04-05

Similar Documents

Publication Publication Date Title
ATE542137T1 (de) Immunocytokine mit modulierter selektivität
NO990560L (no) Kjemisk modifiserte polypeptider
YU27999A (sh) Preparati ob fuzionog proteina i postupci
DE69131580D1 (de) GDF-1 und UOG1 Proteine
DE69931507D1 (de) Interferon-beta fusionsproteine und deren verwendungen
ATE388165T1 (de) Menschliches cnp-gen und vorläuferprotein
EE200700058A (et) Glkoslitud interferoon-beeta, selle kasutamineja seda sisaldav farmatseutiline kompositsioon, meetod interferoon-beeta-1a aktiivsuse pikendamiseks ja leiutisekohase valgu valmistamiseks
ZA200200789B (en) Multiple cytokine-antibody complexes.
IT8367525A0 (it) Proteina ibrida comprendente frammenti proteici collegati da legami peptidici e relativo gene di fusione composizione contenente tale proteina
ATE317441T1 (de) Cathepsin-02-protease
ATE171596T1 (de) Neue gegen phtiraptera aktive bcillus thuringiensis isolate
DE69636714D1 (de) G-CSF TPO Fusionsproteine
DE69837085D1 (de) Crsp-proteine (cystein-reiche, sekretierte proteine), die dafür kodierenden nukleinsäuren und ihre verwendungen
ATE364703T1 (de) Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
NO953882D0 (no) Biologisk aktive polypeptidfusjonsdimerer
AU1431188A (en) Dihydropyridine - pyridinium salt-type redox amino acids and peptides containing them
EP1558729A4 (de) Schnell abgebaute reporter-fusionsproteine
FI953422A0 (fi) Autolysoivia fuusioproteiineja hyväksikäyttävät ilmentämisjärjestelmät ja uusi pelkistävä polypeptidi
NO950420D0 (no) Interferon endelse derav
NO894573L (no) Rekombinante interleukin-2 hybridproteiner.
DE69534738D1 (de) Leukocyten-aktivierender Faktor
WO2000049039A3 (de) Glucose-dehydrogenase-fusionsproteine und ihre verwendung in expressionssystemen
SE8800981D0 (sv) A recombinant fusion protein, its use and a recombinant vector
DE68917520D1 (de) Verfahren und Systeme zur Herstellung von HIV-Antigenen.
ATE332923T1 (de) Cr1 fragmente und deren verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee